Bioventix PLC (LON:BVXP – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of GBX 1,669.32 and traded as high as GBX 2,045. Bioventix shares last traded at GBX 1,950, with a volume of 22,896 shares changing hands.
Bioventix Stock Performance
The company’s 50 day moving average price is GBX 1,678.64 and its 200-day moving average price is GBX 1,657.75. The company has a market cap of £105.39 million, a price-to-earnings ratio of 14.35 and a beta of 0.54.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
See Also
- Five stocks we like better than Bioventix
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
